Skip to content

A Study on the Effect of Food Containing Plant Extract on Platelet Aggregation -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-

A Study on the Effect of Food Containing Plant Extract on Platelet Aggregation -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- - A Study on the Effect of Food Containing Plant Extract on Platelet Aggregation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000042940
Enrollment
60
Registered
2021-01-08
Start date
2021-01-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy men and women aged 40 to 64 years old. (2) Subjects with a BMI < 30. (3) Subjects who can make self-judgment and voluntarily give written informed consent.

Exclusion criteria

Exclusion criteria: (1)Subjects who have a chronic disease and regularly use medications. (2) Subjects who cannot stop using supplements, and/or functional foods (including Food for Specified Health Uses or Foods with Function Claims) during the test periods. (3) Subjects with a history and/or presence of serious diseases (e. g., liver disease, kidney disease, heart disease, respiratory disease, endocrine disease, and/or metabolic disease). (4) Subjects who had a history of digestive diseases and/or underwent a surgical procedure for digestive disease. (5) Subjects who declared allergic reactions to foods. (6) Subjects who had excessive alcohol intake of > 60 g/day of pure alcohol equivalent or habit of drinking not less than five days a week. (7)Subjects with a history of and/or current drug addiction and/or alcoholism. (8) Subjects unable to cease drinking for two days before each measurement. (9) Subjects who are shift workers and/or night-shift workers. (10) Subjects who were pregnant or planned to become pregnant or breastfeed during the study period. (11) Subjects who had donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the three months prior to the current study. (12) Subjects who were planning to participate and/or had participated in other clinical studies within the month prior to the commencement of the current study. (13) Subjects who were judged as unsuitable for the current study by screening tests. (14) Subjects who were judged as unsuitable for the current study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
platelet aggregation

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales department

yoshi@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026